Ozempic and Wegovy May Boost Bone Strength in Type 2 Diabetes

A study indicates that semaglutide, used in drugs like Ozempic and Wegovy for weight loss and blood sugar control in type 2 diabetes patients, may also strengthen bones and reduce fracture risk. Researchers found that patients taking semaglutide were 15% less likely to suffer fractures compared to those on other weight-loss medications. The findings, based on medical records of over 59,000 adults, suggest potential bone health benefits alongside weight loss, especially relevant for older adults at risk for bone loss.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article